About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Ataxia
Patient Information:
Medical History:
Treatment: Stereotactic Brain Procedure Surgery combined with Nerve Growth Factor Transplantation, Traditional Chinese Medicine (TCM), and Physical Therapy at Beijing Puhua International Hospital (BPIH)
Medical Condition before Treatment:
Treatment Course:
After admission to BPIH, José completed relevant examinations, and the following medical protocols were applied:
The entire treatment course lasted for two weeks.
Medical Condition after Treatment:
Immediately following the stereotactic brain procedure surgery combined with nerve growth factor transplantation:
Post-Treatment Outlook:
Further changes would require follow-up assessment and cannot be predicted from this account. BPIH will continue to monitor his progress closely.
About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Ataxia
Patient Information:
Treatment: Neural Growth Factor Therapy, supplemented with cerebral blood circulation improvement and nutritional therapy
Medical History:
Omar, a 35-year-old male, was admitted to Beijing Puhua International Hospital in June 2014. He reported decreased vision for the previous eight years and unsteady gait with slurred speech for the past three years. He was diagnosed with hereditary cerebellar ataxia.
Medical Condition before Treatment:
Treatment Course:
Omar underwent Neural Growth Factor Therapy, combined with additional treatments focusing on improving cerebral blood circulation and nutrition. This was supplemented with Traditional Chinese Medicine (TCM) and rehabilitation training.
Post-Treatment Updates:
Upon discharge, Omar demonstrated significant improvements in:
Post-Discharge Outlook:
Further changes would require follow-up assessment and cannot be predicted from this account.
About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Ataxia
Patient Information:
Treatment: Nerve Growth Factor Treatment, Cerebral Metabolism Improving Treatment, Neurotrophic Treatment, Traditional Chinese Medicine (TCM), and Rehabilitation Therapy
Medical History:
Mouayad was admitted to Puhua International Hospital on May 31st, 2011, presenting with a 10-year history of unsteady walking. He was diagnosed with hereditary ataxia.
Medical Condition before Nerve Growth Factor Treatment for Hereditary Ataxia:
Post-admission examinations revealed:
Treatment Course:
Mouayad underwent Nerve Growth Factor Treatment, focusing on cerebral metabolism improvement and neurotrophic effects. This was complemented by Traditional Chinese Medicine (TCM) and comprehensive rehabilitation therapy.
Post-Treatment Updates:
Following Nerve Growth Factor Treatment for Hereditary Ataxia:
About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Ataxia
Patient Information:
Treatment: Neural Growth Factor Therapy for Hereditary Ataxia, Cerebral Metabolism Improvement Treatment, Neurotrophic Treatment, Traditional Chinese Medicine (TCM), and Rehabilitation Therapy
Medical History:
Kreem was admitted to Puhua International Hospital on May 31st, 2011, presenting with unsteady walking that had progressed over seven years. He was diagnosed with hereditary ataxia.
Medical Condition before Neural Growth Factor Treatment for Hereditary Ataxia:
At admission:
Treatment Course:
Kreem underwent Neural Growth Factor Therapy targeting cerebral metabolism improvement and neurotrophic effects. This was combined with Traditional Chinese Medicine (TCM) and comprehensive rehabilitation therapy.
Post-Treatment Updates:
Following Neural Growth Factor Treatment for Hereditary Ataxia:
Patient & Family Feedback:
Kreem and his parents were highly satisfied with the results of his Neural Growth Factor Therapy. They expressed optimism regarding further improvements in Kreem's condition after discharge from Puhua Hospital.